April 29, 2019 / 5:05 AM / a month ago

BRIEF-Santhera Pharmaceuticals FY Net Result At CHF -54.2 Mln

April 29 (Reuters) - SANTHERA PHARMACEUTICALS HOLDING AG :

* FY 38% INCREASE IN NET REVENUES YEAR-ON-YEAR TO CHF 31.7 MILLION (2017: CHF 22.9 MILLION)

* FY NET RESULT AMOUNTED TO CHF -54.2 MILLION (2017: CHF -51.5 MILLION)

* IN Q1 GREW SALES OF RAXONE FOR LHON BY 19% YEAR-ON-YEAR, REACHING CHF 9.2 MILLION (Q1-2018: CHF 7.7 MILLION)

* EXPECTS CONTINUED STRONG GROWTH AND PROJECTS NET SALES OF RAXONE IN CURRENTLY APPROVED INDICATION LHON TO REACH CHF 35-37 MILLION IN 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below